NASDAQ: ATEC

⬣ Investigation

healthcare

Alphatec Holdings, Inc.

Securities Investigation

Stock dropped 40% on October 30, 2026

Investors who purchased or acquired ATEC securities are encouraged to come forward.

Investigation in Progress — No Complaint Filed Yet

BG&G is actively investigating potential securities fraud claims against Alphatec Holdings, Inc.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.

Why Is Alphatec Holdings, Inc. (ATEC) Under Investigation?

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of shareholders of Alphatec Holdings, Inc. (NASDAQ: ATEC).

On October 29, 2026, Alphatec announced third-quarter 2026 financial results, reporting adjusted earnings per share of $0.09 and revenue of $221.2 million, both below analysts’ expectations. The Company also lowered its full-year 2026 revenue guidance to approximately $862 million from approximately $882 million, citing lower biologics attachment rates, softer procedure volumes, EOS timing, and a temporary international supply constraint. During the Company’s second quarter 2026 earnings call, Chief Financial Officer J. Todd Koning stated, “Turning to the revenue outlook, we are maintaining our full-year revenue guidance of approximately $882 million, representing growth of roughly 15% for the year.” Following this news, Alphatec Holdings’ stock price fell nearly 40% at market open on October 30, 2026.

What Potential Securities Violations Is BG&G Investigating?

  • Whether Alphatec Holdings, Inc. and certain of its officers made false or misleading statements regarding the Company's financial condition and business prospects.
  • Whether Alphatec Holdings, Inc. failed to disclose material adverse information that would have been significant to a reasonable investor.
  • Whether the Company's earnings guidance was supported by a reasonable factual basis at the time it was made.

What Should Alphatec Holdings, Inc. (ATEC) Investors Do?

If you purchased or acquired ATEC securities and suffered a loss, you may have a claim.
Contact BG&G to share relevant facts or information about your purchase.
There is no cost or obligation — our firm works exclusively on a contingency fee basis.
You do not need to have sold your shares to contact us.

How Is Alphatec Holdings, Inc. (NASDAQ: ATEC) Stock Trading Today?

Interactive chart showing the weekly share price history of NASDAQ:ATEC (NASDAQ:ATEC).

How Does BG&G Help Investors in Securities Fraud Investigations?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

We handle cases on a contingency fee basis — we advance all litigation costs on your behalf. There is no fee unless we are successful.

“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”
— Peretz Bronstein, Founding Partner